Genfit SA (GNFT)
4.20
-0.04
(-0.94%)
USD |
NASDAQ |
Nov 22, 16:00
4.21
+0.01
(+0.24%)
After-Hours: 20:00
Genfit Revenue (Annual): 30.92M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.92M |
| December 31, 2022 | 21.30M |
| December 31, 2021 | 94.74M |
| December 31, 2020 | 0.8737M |
| December 31, 2019 | 34.52M |
| December 31, 2018 | 0.0815M |
| December 31, 2017 | 0.1336M |
| December 31, 2016 | 0.3143M |
| December 31, 2015 | 0.5848M |
| December 31, 2014 | 2.146M |
| Date | Value |
|---|---|
| December 31, 2013 | 2.522M |
| December 31, 2012 | 2.15M |
| December 31, 2011 | 3.292M |
| December 31, 2010 | 4.981M |
| December 31, 2009 | 8.105M |
| December 31, 2008 | 12.86M |
| December 31, 2007 | 12.99M |
| December 31, 2006 | 12.63M |
| December 31, 2005 | 15.90M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.8737M
Minimum
2020
94.74M
Maximum
2021
36.47M
Average
30.92M
Median
2023
Revenue (Annual) Benchmarks
| Edap TMS SA | 65.41M |
| DBV Technologies SA | -- |
| Cellectis SA | 0.755M |
| Adaptimmune Therapeutics PLC | 60.28M |
| Akari Therapeutics PLC | -- |